Nancy Miller-Rich bought $10k of ALDX
director at Aldeyra Therapeutics, Inc.. 922 shares at an average of $11.33, traded May 3, 2021, filed Oct 21, 2024.
Score components
- +15RoleDirector
- 0Trade size$10k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -13.9%, 3m -12.5%, 6m -59.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-116048, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 3, 2021 | POpen-market purchase Common Stock | +413 | $12.81 | $5,291 | 413 | Oct 21, 2024 |
| Apr 12, 2023 | POpen-market purchase Common Stock | +509 | $10.13 | $5,156 | 922 | Oct 21, 2024 |
Related signals
Other insiders at Aldeyra Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 27Weak | ALDXbuy Aldeyra Therapeutics, Inc. | Michael Alfieri Principal Financial Officer | $13k 2,500 shares | - | |
| 25Weak | ALDXsell Aldeyra Therapeutics, Inc. | Stephen Machatha Chief Development Officer | $114k 22,073 shares | -9% | |
| 47Moderate | ALDXsell Aldeyra Therapeutics, Inc. | Perceptive Advisors LLC owner | $4.8M 3,400,000 shares | -37% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.